Skip directly to Accessibility Notice
UCTCYBO VanEck Bionic Engineering UCITS ETF | CYBO Please read important disclosure Close important disclosure true de en false false

Bionic ETF
VanEck Bionic Engineering UCITS ETF | CYBO

Bionic ETF
VanEck Bionic Engineering UCITS ETF | CYBO

  • NAV

    as of 30 Nov 2023

    as of 30 Nov 2023
  • Total Net Assets
    $5.1 million

    as of 30 Nov 2023
  • Total Expense Ratio
  • Inception Date
    02 Dec 2022
  • SFDR Classification
    Article 9


Fund Description

As the global population ages, so does the demand for biologically-inspired systems that improve the quality of later life. VanEck’s Bionic Engineering ETF tracks the performance of the portfolio of innovative companies delivering medical, dental or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue.

  • Invest in companies at the forefront of improving quality of life for the world’s ageing population
  • Gain diversified exposure to companies involved in medical implants and bionic enhancements for chronic diseases and functional impairments
  • Access companies earning at least half their revenues from bionic engineering-related industries
  • Invest in an ETF that screens out companies that violate social norms, derive revenues from controversial weapons, or participate in fossil fuel sectors, nuclear power, civilian firearms or tobacco

Risk Factors: Equity market risk, industry or sector concentration risk, risk of investing in smaller companies, technological risk. Please refer to the


and the Prospectus for other important information before investing.

Underlying Index

MVIS® Global Bionic Healthcare ESG Index (MVBIONTR)





Important Information

Capital Requirements Report (CRR) Download
GroMiKV Report Download
VAG Report Download

Discover more ETFs

More ETFs